The numerals presented in Table 2 “Relative advantages and disadvantages of each approach to haploBMT” were incorrectly formatted as non-bold numerals in several places in the print version of this article. This error has been corrected in the online versions of the article.
Additional information
The online version of the original article can be found at 10.1038/nrclinonc.2015.128
Rights and permissions
About this article
Cite this article
Kanakry, C., Fuchs, E. & Luznik, L. Erratum: Modern approaches to HLA-haploidentical blood or marrow transplantation.. Nat Rev Clin Oncol 13, 132 (2016). https://doi.org/10.1038/nrclinonc.2015.234
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrclinonc.2015.234
This article is cited by
-
Effect of graft-versus-host disease on outcomes of HLA-haploidentical peripheral blood transplantation using post-transplant cyclophophamide
Bone Marrow Transplantation (2024)
-
GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT
Journal of Hematology & Oncology (2023)
-
Immunotherapy in hematologic malignancies: achievements, challenges and future prospects
Signal Transduction and Targeted Therapy (2023)
-
The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML
Bone Marrow Transplantation (2022)
-
Engraftment syndrome following Hematopoietic stem cell transplantation: a systematic approach toward diagnosis and management
Medical Oncology (2022)
